Hygiena 2009, 54(4):117-121

Czech Armed Forces Programme of Extensive Primary Care

Hana Střítecká, Pavol Hlúbik
Univerzita obrany, Fakulta vojenského zdravotnictví, Katedra vojenské hygieny, Hradec Králové

From 1999 in the Czech Army a programme of Primary Preventive Care (PPC) is being implemented - this PPC is for soldiers of assorted professions, functions and education in age group (25, 30, 33, 36, 39, 40-55 year). The number of examined is about 6,000-per year. Anthropometrical, laboratory and clinical knowledge give sufficient information about everyone and so it is possible to determine individual medication and preventive recommendations. The objective of those recommendations is to retard the manifestation of foremost civilization-linked diseases (diabetes mellitus type II, metabolic disorders, dyslipidaemia, hypertension, atherosclerosis, ...). These diseases are the most frequent reason of temporary or lasting disability in duty of Czech soldiers during the last few years. It is impossible not to mention negative influence of other risk factors such as stress, smoking, overweight, obesity, bad eating habits, live style and age.

Keywords: primary care, obesity, cardiovascular risk, Czech Army, physical activity, life style

Received: February 2009; Accepted: June 4, 2009; Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Střítecká H, Hlúbik P. Czech Armed Forces Programme of Extensive Primary Care. Hygiena. 2009;54(4):117-121.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005 Aug;21(8):1157-9. Go to original source... Go to PubMed...
    2. Bláha V. Dyslipoproteinemie - obecný přehled, diagnostika a léčba. Causa Subita. 2005;8(1):34-8.
    3. Bloomgarden ZT. Obesity, hypertension, and insulin resistance. Diabetes Care. 2002 Nov;25(11):2088-97. Go to original source...
    4. Cífková R. Studie Monica v České republice - 25 let. Med Tribune. 2008;4(36):A10.
    5. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005 Sep 10-16;366(9489):895-906. Go to original source... Go to PubMed...
    6. Diogenes [homepage on the Internet]. Targeting the obesity problem: seeking new insights and routes to prevention [cited 2009 Jun 4]. Available from: http://www.diogenes-eu.org/.
    7. European Association for the Study of obesity [homepage on the Internet]. EU Platform on diet, physical actiRok vyšetøení Celkem osob % mužů % žen 2008 8067 89,23 10,77 2007 6811 89,55 10,45 2006 6761 89,47 10,53 2005 5854 90,09 9,91 2004 5712 88,67 11,33 2003 5865 91,01 8,99 2002 6324 91,24 8,76 2001 6717 93,43 6,57 2000 6997 94,51 5,49 1999 6610 99,98 0,02
    8. European Union [homepage on the Internet]. Eurodiet: nutrition and diet for healthy lifestyles in Europe [cited 2009 Jun 4]. Available from: http://europa.eu.int/comm/health/ph_determinants/life_style/nutrition/report01_en.pdf.
    9. International Obesity TaskForce IOTF [homepage on the Internet]. Global prevalence of adult obesity [cited 2009 Jun 4]. Available from: http://www.iotf.org/database/documents/GlobalPrevalenceofAdultObesityJanuary2009v2.pdf.
    10. Malcolm KR, Abraham T, editors. Obesity and cardiovascular disease. London: Taylor & Francis; 2006.
    11. Müllerová D, Sucharda P, Matějková D. Kouření a obezita. Plzeň Lék Sbor. 2004;71:127-30.
    12. Reaven G. Metabolic syndrome: pathophysiology and implication for management of cardiovascular disease. Circulation. 2002 Jul;106(3):286-8. Go to original source...
    13. Rosolová H, Šimon J. Community related life style intervention reduces coronary risk in the population. Eur Heart J. 2000 Oct;21(19):1562-3. Go to original source... Go to PubMed...
    14. Rosolová H. Metabolický syndrom. Editorial. Remedia. 2006;16(2):130-2.
    15. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000 Mar 11;355(9207):865-72. Go to original source...
    16. Widimský J Jr, Cífková R, Špinar J, Filipovský J, Grundmann M, Horký K, a kol. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007: doporučení České společnosti pro hypertenzi. Cor Vasa. 2008;50(1): K3-K16.
    17. World Health Organization. Diet, nutrition and the prevention of chronic diseases. Technical Report Series no. 916. Geneva: WHO; 2003.

    Return to the content